Emerging Pharmaceutical markets Argentina and Mexico

Table of Contents

• CHAPTER 1 EXECUTIVE SUMMARY
  • Scope of the report
  • Key findings
    • Argentina
    • Mexico
  • IMS caveat
• CHAPTER 2 THE PHARMACEUTICAL MARKET IN ARGENTINA
  • Argentina has stable macroeconomic factors, some of which must be strengthened
  • A growing pharmaceutical market dominated by branded generics
  • Demographic trends in Argentina
  • Disease burden in Argentina
  • Socioeconomic environment in Argentina
    • Political climate in Argentina - stable
    • GDP has been growing after the economic crisis of 2001
    • Regional differences - the fight for equality continues
    • Mercosur established free trade between the countries involved
  • Corporate environment in Argentina
    • Foreign direct investment in Argentina is modest
    • Taxation system in Argentina
  • The healthcare system in Argentina
    • Healthcare expenditure in Argentina is high
    • The public sector is decentralized
    • Social health insurance system is fragmented
    • The private sector covers a minority of the population
    • The hospital capacity within the public sector has declined while the private sector has been growing
  • Regulatory issues in Argentina
    • IP protection has improved but is still inadequate
      • A significant effort has been made to reduce the patent backlog in Argentina
    • Registration of drugs in Argentina is a straight forward procedure
    • Advertising of pharmaceuticals is strictly controlled
    • Import of pharmaceuticals has been facilitated by Mercosur agreement
    • Drug counterfeiting has been reduced by a number of measures
  • Pricing and reimbursement of pharmaceuticals in Argentina
    • Pricing of pharmaceuticals in Argentina
      • The Generics Law, resulted in lower prices and increased access to pharmaceuticals
      • Antiretroviral therapy prices were decreased
    • Reimbursement of pharmaceuticals in Argentina
      • Remediar program, introduced in 2002, increased drug access to the poor
  • Pharmaceutical market dynamics in Argentina
    • Branded generics dominate the Argentinean market
    • Top three distributors dominate while retail pharmacy chains are expanding
    • Top manufacturers on the Argentinean retail market
    • Top ATC groups by sales value on the Argentinean retail market
    • Top brands on the Argentinean retail market
    • Import and export of pharmaceuticals - demand for foreign drugs remains high
    • Major foreign pharmaceutical companies in Argentina
      • Pfizer
      • Bayer
      • Roche
    • Major domestic pharmaceutical companies in Argentina
      • Roemmers
      • Bagó - collaboration and geographical expansion are driving growth
      • Phoenix
  • Clinical trials in Argentina - an underused opportunity
• CHAPTER 3 THE PHARMACEUTICAL MARKET IN MEXICO
  • Growth of the Mexican economy and strengthened intellectual property rights are boosting pharma industry
  • The Mexican pharmaceutical market is dominated by foreign companies and is attracting a lot of clinical research
  • Demographic trends in Mexico
  • Disease burden in Mexico
  • Socioeconomic environment in Mexico
    • Political climate in Mexico
    • GDP has increased since the introduction of NAFTA
    • Regional differences - some rural areas are in extreme poverty
    • NAFTA eliminated tariffs between the US, Canada and Mexico, and boosted the Mexican economy
  • Corporate environment in Mexico
    • Taxation system in Mexico
    • Foreign direct investment in Mexico was boosted by NAFTA agreement
  • The healthcare system in Mexico
    • Healthcare system reforms in Mexico - the national health system aims to provide choice of healthcare provider
    • Healthcare expenditure in Mexico is low
    • The social security sector
    • Governmental services headed by the Ministry of Health are designed to offer coverage to the poor and uninsured
    • Only a small proportion of the population has private health insurance
  • Regulatory issues in Mexico
    • Intellectual property (IP) protection has significantly improved
    • Registration of drugs in Mexico is simple
    • Physicians play an important role in drug choices
    • Import of pharmaceuticals in Mexico is facilitated by NAFTA
    • Counterfeit drugs are a persistent problem in Mexico
  • Pricing and reimbursement of pharmaceuticals in Mexico
    • Pricing of pharmaceuticals in Mexico
    • Reimbursement in Mexico
  • Pharmaceutical market dynamics in Mexico
    • Mexico classifies generics into three segments
    • Market growth is driven mainly by growing preference and demand for high-value products and not by volume growth
    • Distribution of pharmaceuticals in Mexico is dominated by two distributors
    • Pharmacies selling cheap pharmaceuticals are very popular in Mexico
    • Top pharmaceutical companies in Mexico-multinationals dominate
    • Top ATC groups by sales value on the Mexican retail market
    • Top brands on the Mexican retail market
    • Import and export of pharmaceuticals have increased since NAFTA came into place
    • Major foreign pharmaceutical companies in Mexico
      • Sanofi-Aventis
      • Pfizer
      • AstraZeneca
    • Major domestic pharmaceutical companies in Mexico
      • Senosiain
  • Clinical trials in Mexico - an attractive opportunity for US companies
• CHAPTER 4 BIBLIOGRAPHY
  • Publications and online articles
  • Datamonitor resources
  • Glossary of Terms
  • List of Tables
    • Table 1: Demographic indicators for Argentina, 2005
    • Table 2: Average annual growth rate of GDP and exports in Argentina, 1998-2010 (%),
    • Table 3: Key economic indicators for Argentina, 1986-2006
    • Table 4: Health expenditure indicators in Argentina, 2004
    • Table 5: Density of healthcare workers and hospital capacity in Argentina, 1998
    • Table 6: Argentina - Growth of pharmaceutical market in terms of sales volume, 2003-06
    • Table 7: Argentina - Average cost of unit sold, 2003-06
    • Table 8: Branded generics dominate the Argentinean pharmaceutical market, 2006
    • Table 9: Top 15 drug manufacturers in Argentina, 2006
    • Table 10: Market segmentation in Argentina according to ATC groups, 2006
    • Table 11: Top 15 brands in Argentina, 2006
    • Table 12: Key demographic indicators for Mexico, 2005
    • Table 13: Mexico -average annual growth rates of GDP and exports (%), 1986-2010
    • Table 14: Key economic indicators for Mexico, 1986-2006
    • Table 15: Health expenditure indicators in Mexico, 2004
    • Table 16: Growth of the Mexican market in terms of sales volume, 2003-06
    • Table 17: Average cost of unit sold, 2003-06
    • Table 18: Top 15 drug manufacturers in Mexico in 2006
    • Table 19: Growth of ATC group split in the Mexican market, 2006
    • Table 20: Top 15 brands in 2006 in Mexico
  • List of Figures
    • Figure 1: Key macroeconomic factors and healthcare system characteristics impacting the pharmaceutical industry in Argentina, 2008
    • Figure 2: Pharmaceutical market dynamics in Argentina, 2008
    • Figure 3: Structure of health system financing and provision in Argentina
    • Figure 4: The size of the Argentinean retail pharmaceutical market, 2002-06
    • Figure 5: Sales growth and CAGR for the top ATC groups in Argentina
    • Figure 6: The relative market share for each ATC group in Argentina is very similar to the six major markets
    • Figure 7: Clinical trial protocols assessed and approved, 1994-2006
    • Figure 8: Multinational pharmaceutical companies sponsor the majority of clinical research in Argentina
    • Figure 9: Advantages and disadvantages of carrying out clinical trials in Argentina
    • Figure 10: Key macroeconomic factors and healthcare system characteristics impacting the pharmaceutical industry in Mexico
    • Figure 11: Pharmaceutical market dynamics in Mexico
    • Figure 12: The three pricing regulations in Mexico
    • Figure 13: Decision process for listing pharmaceuticals on the Basic Formulary and the Catalogue of Inputs
    • Figure 14: The size of the Mexican retail pharmaceutical market, 2002-06
    • Figure 15: Sales growth and CAGR for the top ATC groups in Mexico, 2006
    • Figure 16: The relative market shares of each ATC groups are very similar between Mexico and the six major markets
    • Figure 17: Advantages and disadvantages of carrying out clinical trials in Mexico